col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


52 Results       Page 1

 [1] 
APO Society of Specialists in Heart Failure: Kardiologiia
  original article Date Title Authors   All Authors
1 [GO] 2023―Dec―29 Predictors of Reduced Left Ventricle Global Longitudinal Strain One Year After COVID-19 Pneumonia E. I. Yaroslavskaya, E. A. Gorbatenko, D. V. Krinochkin, N. E. Shirokov, N. A. Osokina, A. V. Migacheva, T. I. Petelina
2 [GO] 2023―Nov―16 Association of cardiovascular disease with hospital mortality in COVID-19 patients N. V. Pogosova, M. V. Ezhov, I. V. Barinova, A. K. Ausheva, D. T. Kuchiev, A. B. Popova, et al. (+2)
3 [GO] 2023―Sep―12 Clinical and Morphological Features of Myocardial Infarction in Patients With a New Coronavirus Infection COVID-19 M. V. Zavyalova, A. A. Neklyudov, A. V. Zavyalov, E. S. Andryukhova, Yu. M. Paderov, M. V. Balakhonova, et al. (+2)
4 [GO] 2023―Sep―12 Condition of the Right Heart in Patients With COVID-19-Associated Pneumonia: Follow-Up During Hospitalization N. G. Poteshkina, N. S. Krylova, A. A. Karasev, T. A. Nikitina, I. P. Beloglazova, E. A. Kovalevskaya, et al. (+4)
5 [GO] 2023―Aug―01 Effects of coronary artery calcified plaque and stent on severity and survival of COVID-19 patients: a decision tree model study Burcu Akman, Ahmet Turan Kaya
6 [GO] 2023―Jun―13 Features of echocardiographic examination in patients with COVID-19 E. Z. Golukhova, I. V. Slivneva, M. L. Mamalyga, M. N. Alekhin
7 [GO] 2023―Mar―07 Cardiohemodynamic Changes and Cardiac Arrhythmias After Coronavirus Infection M. V. Chistiakova, A. V. Govorin, D. N. Zaitsev, T. V. Kalinkina, N. A. Medvedeva, A. A. Kurokhtina, R. O. Chistyakov
8 [GO] 2023―Feb―07 Features of Left Atrial Appendage Thrombosis in Patients With Persistent Nonvalvular Atrial Fibrillation After COVID-19 E. S. Mazur, V. V. Mazur, N. D. Bazhenov, O. V. Nilova, T. O. Nikolaeva
9 [GO] 2023―Jan―13 Анализ влияния коморбидной сердечно-сосудистой патологии на течение и исходы COVID-19 у госпитализированных пациентов в первую и вторую волну пандемии в Евразийском регионе Григорий Павлович Арутюнов, Екатерина Иосифовна Тарловская, Александр Григорьевич Арутюнов, Юрий Никитич Беленков, Александра Олеговна Конради, Юрий Михайлович Лопатин, et al. (+192)
10 [GO] 2023―Jan―12 Electrocardiogram QRS Complex Duration as a Predictor of Hospital Prognosis in Patients With COVID-19 I. V. Kovtyukh, A. M. Baymukanov, G. E. Gendlin, I. G. Nikitin, S. N. Dvornikova, Olga Roginko
11 [GO] 2023―Jan―12 Case of peripartum cardiomyopathy misdiagnosed as pulmonary changes due to COVID-19 D. V. Gavrilov, Z. R. Bagirova, D. I. Pleskatsevich, O. V. Kuznetsova, A. A. Ivshin, T. Yu. Kuznetsova
12 [GO] 2023―Jan―12 Proactive anti-inflammatory therapy in the advanced stages of a new coronavirus infection. Main results of the inpatient phase of the COLORIT study (Colchicin vs. Ruxolitinib and secukinumab in an open, prospective, randomized trial in patients with novel coronavirus infection COVID-19) V. Yu. Mareev, Yа. A. Orlova, A. G. Plisuk, E. P. Pavlikova, Z. A. Akopyan, S. T. Matskeplishvili, et al. (+14)
13 [GO] 2023―Jan―12 The Effect of COVID-19 on Long-Term Cardiac Function in Patients With Chronic Heart Failure A. A. Ageev, M. V. Kozhevnikova, A. V. Emelyanov, A. V. Krivova, Yu. F. Shumskaya, L. M. Musaeva, et al. (+5)
14 [GO] 2022―Nov―17 The Burden of Residual SymptOms That Complicate the Life of Patients Who Have Suffered a new Coronavirus Infection (THROW study) Ya. A. Orlova, Yu. V. Mareev, V. Yu. Mareev, A. G. Plisyk, Yu. L. Begrambekova, Z. A. Akopyan, et al. (+4)
15 [GO] 2022―Oct―10 A case of clinically malignant rapid-progressive cardiac myxoma after COVID-19 infection E. I. Tsoi, A. Yu. Falkovskaya, V. V. Evtushenko, V. F. Mordovin
16 [GO] 2022―Oct―10 The relationship between pericardial effusion and pulmonary involvement, prognosis, mortality in COVID-19 patients İbrahim Saraç, Gökhan Tonkaz, Emrah Aksakal, Faruk Aydınyılmaz, Kaan Alişar, Sidar Şiyar Aydın, et al. (+4)
17 [GO] 2022―Sep―06 The use of an Inhaled Surfactant in Patients With Severe and Extremely Severe new Coronavirus Infection COVID-19 With Concomitant Cardiovascular Pathology N. A. Trofimov, V. E. Babokin, A. V. Dubova, A. V. Koshelkova, O. V. Dimitrieva, A. L. Rodionov, et al. (+8)
18 [GO] 2022―Jun―13 Features of the course of non-ST elevation myocardial infarction in patients with a history of COVID-19 M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina, I. V. Kositsyna, A. V. Golubev, N. I. Chaus, S. N. Perekhodov
19 [GO] 2022―Apr―13 Hidden systolic dysfunction of the right ventricle in patients with increased pulmonary vascular resistance 3 months after COVID-19 pneumonia N. E. Shirokov, E. I. Yaroslavskaya, D. V. Krinochkin, N. A. Osokina
20 [GO] 2022―Apr―13 The left atrial appendage thrombosis of in patients with persistent atrial fibrillation after the novel coronavirus infection E. S. Mazur, V. V. Mazur, N. D. Bazhenov, M. Ye. Kunitsina
21 [GO] 2022―Apr―13 Pathophysiological basis and diagnosis of the cardiovascular system damage caused by coronavirus infection E. K. Serezhina, A. G. Obrezan
22 [GO] 2022―Feb―16 Comparison of clinical and echocardiographic parameters of patients with COVID-19 pneumonia three months and one year after discharge E. I. Yaroslavskaya, D. V. Krinochkin, N. E. Shirokov, E. A. Gorbatenko, I. R. Krinochkina, E. P. Gultyaeva, et al. (+6)
23 [GO] 2021―Dec―09 Acute myocardial infarction and cardiogenic shock in patient with COVID-19 Yu. A. Schneider, V. G. Tsoi, M. S. Fomenko, P. A. Shilenko, I. I. Dimitrova, A. A. Pavlov, et al. (+3)
24 [GO] 2021―Nov―12 The value of indicators characterizing the state of the cardiovascular system in assessing the hospital prognosis of COVID-19 patients I. V. Kovtyukh, G. E. Gendlin, I. G. Nikitin, A. M. Baymukanov, A. E. Nikitin, S. N. Dvornikova
25 [GO] 2021―Nov―12 Case report of mild form of a new coronavirus infection in patient with idiopathic pulmonary hypertension S. E. Gratsianskaya, A. Yu. Demchenkova, T. V. Martynyuk, T. N. Veselova, S. K. Ternovoy
26 [GO] 2021―Nov―11 International register “Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients (ACTIV SARS-CoV-2)” G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, Y. N. Belenkov, A. O. Konradi, Y. M. Lopatin, et al. (+149)
27 [GO] 2021―Oct―29 Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2») E. I. Tarlovskaya, A. G. Arutyunov, A. O. Konradi, Yu. M. Lopatin, A. P. Rebrov, S. N. Tereshchenko, et al. (+194)
28 [GO] 2021―Sep―22 Myocardial injury in COVID-19 patients is associated with the thickness of epicardial adipose tissue Savaş Özer, Eser Bulut, Ali Gökhan Özyıldız, Mustafa Peker, Oğuzhan Ekrem Turan
29 [GO] 2021―Aug―16 The short-term effect of the COVID-19 pandemic on the management of warfarin therapy Doğan Tolga, Levent Fatih
30 [GO] 2021―Jul―27 Clinical observations of COVID-19 infection in patients with chronic thromboembolic pulmonary hypertension O. V. Kamenskaya, I. Yu. Loginova, A. S. Klinkova, V. V. Lomivorotov, A. M. Chernyavsky
31 [GO] 2021―Jul―27 Subacute and chronic post-covid myoendocarditis: clinical presentation, role of coronavirus persistence and autoimmune mechanisms O. V. Blagova, E. A. Kogan, Yu. A. Lutokhina, A. D. Kukleva, D. H. Ainetdinova, V. M. Novosadov, et al. (+6)
32 [GO] 2021―May―17 Cardiac Involvement in COVID-19 A. B. Sugraliyev
33 [GO] 2021―Apr―14 Complicated Course of Coronavirus COVID-19 Infection in the old Patient with Severe Cardiac Pathology: a Clinical Case Study S. A. Boldueva, I. A. Ruslyakova, O. V. Zakharova, M. V. Rozhdestvenskaya
34 [GO] 2021―Apr―14 Effect of COVID-19 Pandemic on Performance Measures in Acute Myocardial Infarction Miguel Alejandro Rodriguez-Ramos
35 [GO] 2021―Mar―15 Clinical Characteristics and Factors Associated with Poor Outcomes in Hospitalized Patients with Novel Coronavirus Infection COVID-19 S. A. Boytsov, N. V. Pogosova, F. N. Paleev, M. V. Ezhov, A. L. Komarov, D. V. Pevsner, et al. (+5)
36 [GO] 2021―Mar―15 Hydroxychloroquine in patients with novel coronavirus infection (COVID-19): a case-control study A. A. Kamalov, V. Yu. Mareev, Ya. A. Orlova, A. G. Plisyk, Z. A. Akopyan, Yu. V. Mareev, et al. (+3)
37 [GO] 2021―Mar―15 Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study V. Yu. Mareev, Ya. A. Orlova, A. G. Plisyk, E. P. Pavlikova, Z. A. Akopyan, S. T. Matskeplishvili, et al. (+15)
38 [GO] 2021―Feb―01 COVID-19 management in heart transplanted recipients: registry of Almazov National Medical Research Centre M. A. Simonenko, P. A. Fedotov, Yu. V. Sazonova, K. I. Monosova, M. Yu. Sitnikova, G. V. Nikolaev, et al. (+2)
39 [GO] 2021―Jan―25 Right ventricular systolic dysfunction as a predictor of adverse outcome in patients with COVID-19 E. Z. Golukhova, I. V. Slivneva, M. M. Rybka, M. L. Mamalyga, D. I. Marapov, I. V. Klyuchnikov, et al. (+2)
40 [GO] 2021―Jan―25 How evaluate results of treatment in patients with COVID-19? Symptomatic Hospital and Outpatient Clinical Scale for COVID-19 (SHOCS-COVID) V. Yu. Mareev, Yu. L. Begrambekova, Yu. V. Mareev
41 [GO] 2020―Nov―06 QT Interval in Patients With COVID-19 V. N. Komoliatova, L. M. Makarov
42 [GO] 2020―Nov―06 Myopericaditis as a late manifestation of the probable COVID-19 L. N. Chikhireva, O. A. Chikhirev, D. A. Pikin, O. P. Bychkova, A. M. Cherkashov, Yu. N. Belenkov
43 [GO] 2020―Nov―06 ECG changes in COVID-19 G. V. Ryabykina
44 [GO] 2020―Nov―06 Cardiovascular Pathology in Patients With COVID-19 E. K. Serezhina, A. G. Obrezan
45 [GO] 2020―Nov―06 Combination therapy at an early stage of the novel coronavirus infection (COVID-19). Case series and design of the clinical trial “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)” V. Yu. Mareev, Ya. A. Orlova, E. P. Pavlikova, S. T. Matskeplishvili, Z. A. Akopyan, A. G. Plisyk, et al. (+12)
46 [GO] 2020―Nov―06 Miocarditis in Patients with COVID-19 Confirmed by Immunohistochemical E. A. Kogan, Yu. S. Berezovskiy, O. V. Blagova, A. D. Kukleva, G. A. Bogacheva, E. V. Kurilina, et al. (+6)
47 [GO] 2020―Nov―02 Proactive anti-inflammatory and anticoagulant therapy in the treatment of advanced stages of novel coronavirus infection (COVID-19). Case Series and Study Design: COLchicine versus ruxolitinib and secukinumab in open prospective randomIzed trial (COLORIT) V. Yu. Mareev, Ya. A. Orlova, E. P. Pavlikova, Z. A. Akopyan, S. T. Matskeplishvili, A. G. Plisyk, et al. (+12)
48 [GO] 2020―Jul―28 Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study) V. Yu. Mareev, Ya. A. Orlova, E. P. Pavlikova, S. T. Matskeplishvili, T. N. Krasnova, P. S. Malahov, et al. (+7)
49 [GO] 2020―Jul―28 Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19. The Agreed Experts’ Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association Ye. V. Shlyakhto, G. P. Arutyunov, Yu. N. Belenkov, E. I. Tarlovskaya, A. O. Konradi, E. P. Panchenko, et al. (+25)
50 [GO] 2020―Jun―09 Recommendations of the Eurasian Arrhythmology Association (EURA) for the diagnosis and treatment of patients with arrhythmias and conduction disorders during the COVID-19 pandemic Yu. N. Belenkov, V. A. Snezhitskiy, A. V. Ardashev, S. A. Abzaliyeva, Riccardo Cappato, J. I. Karpenko, et al. (+11)
51 [GO] 2020―Jun―09 The Agreed Experts’ Position of the Eurasian Association of Therapists on Some new Mechanisms of COVID-19 Pathways: Focus on Hemostasis, Hemotransfusion Issues and Blood gas Exchange G. P. Arutyunov, N. A. Koziolova, E. I. Tarlovskaya, A. G. Arutyunov, N. Yu. Grigorjeva, G. A. Dzhunusbekova, et al. (+11)
52 [GO] 2020―May―12 Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers Yu. V. Mareev, V. Yu. Mareev
 [1] 

52 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.007 sec